Market Movers
Pre-Market and After Hours Market Movers
-
Harrow’s MELT Acquisition Could Disrupt IV Sedation—But Is It The Hottest Pharma Small-Cap Buy?
Harrow Inc. targets Melt Pharma buyout to expand sedation portfolio with MELT-300, a sublingual non-IV sedative, aiming for U.S. launch…
Read More » -
3D Systems Hands Over Its Software Crown Jewels — What Hubb Global Gains
3D Systems is divesting Oqton MOS and 3DXpert to Hubb Global Holdings, aiming to sharpen focus on polymers while Hubb…
Read More » -
Reddit Tumbles Again as ChatGPT Citations Shrink
Reddit (RDDT) extended its decline for a second straight day on Wednesday, falling more than 10% after new data showed…
Read More » -
Stock Market Today: Investors Face Uncertainty as Shutdown, Tariffs, and Fed Policy Collide
US stocks struggled on Wednesday after Washington entered its first government shutdown in seven years, raising concerns over the economic…
Read More » -
Semler Scientific’s Quiet Cash Machine Is Fueling A Bitcoin Empire—The Real Reason Behind Strive’s 210% Buyout Offer!
Semler Scientific to merge with Strive Asset Management in all-stock deal at a 210% premium. Shareholders get 21.05 Strive shares…
Read More » -
PROS Gets Thoma Bravo’s Attention: What’s Behind The $1.4 Billion Takeover Buzz?
PROS Holdings to be acquired by Thoma Bravo for $1.4B at $23.25/share, a 41.7% premium. Deal highlights PROS’ CPQ and…
Read More » -
CoreWeave Soars on $14B Meta AI Partnership
CoreWeave (CRWV) shares surged more than 14% on Tuesday after reports that the Nvidia-backed AI data center operator secured a…
Read More » -
Stock Market Today: Dow, S&P 500, Nasdaq Slide as Shutdown Threatens and Confidence Sinks
U.S. stocks traded lower on Tuesday as political turmoil in Washington pushed the government closer to its first shutdown in…
Read More » -
Integral Ad Science Gets Snapped Up? Inside Novacap’s $1.9 Billion Bet On AI Ad Tech
Integral Ad Science to be acquired by Novacap in $1.9B all-cash deal at $10.30/share, 22% premium. Shares jump nearly 20%…
Read More » -
DarioHealth Eyes Sale After Surprise Buyout Interest—What’s Next For This Small-Cap?
DarioHealth launches strategic review after unsolicited interest, exploring sale, merger, or standalone path. Shares jump 40% as investors eye growth,…
Read More »
